|
Marché Fermé -
22:00:00 31/07/2024
|
Varia. 5j.
|
Varia. 1 janv.
|
|
44,96 USD
|
+0,74%
|
 |
-.--%
|
-
|
|
04/04/25 |
Entwistle & Cappucci LLP Files a Securities Class Action Against Cerevel Therapeutics Holdings, Inc., Bain Capital Investors, LLC and Pfizer, Inc.
| | |
31/03/25 |
Entwistle & Cappucci LLP is Investigating Potential Federal Securities Law Violations in Connection with Cerevel Therapeutics Holdings, Inc. (CERE)
| | |
05/08/24 |
Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from S&P Biotechnology Select Industry Index
| | |
05/08/24 |
Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from S&P Global BMI Index
| | |
05/08/24 |
Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from S&P TMI Index
| | |
02/08/24 |
RECOMENDACIONES DE LOS ANALISTAS UK/EE.UU.: Alphabet, Amazon, Lululemon, Intel, Qualcomm....
| | |
02/08/24 |
Analyst recommendations: Alphabet, Amazon, Lululemon, Intel, Qualcomm....
| | |
01/08/24 |
AbbVie Completes Acquisition of Cerevel Therapeutics
| | |
01/08/24 |
AbbVie Completes Acquisition of Cerevel Therapeutics
| | |
01/08/24 |
Cerevel Therapeutics Holdings, Inc. Announces Board Changes
| | |
01/08/24 |
AbbVie Completes Acquisition of Cerevel Therapeutics
| | |
01/08/24 |
Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from NASDAQ Composite Index
| | |
01/08/24 |
AbbVie Inc. completed the acquisition of Cerevel Therapeutics Holdings, Inc. from FMR LLC and others.
| | |
01/07/24 |
Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) added to Russell 1000 Dynamic Index
| | |
01/07/24 |
Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) added to Russell Midcap Growth Index
| | |
01/07/24 |
Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) added to Russell 1000 Index
| | |
01/07/24 |
Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from Russell 2000 Index
| | |
01/07/24 |
Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from Russell 2000 Growth Index
| | |
01/07/24 |
Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) added to Russell Midcap Index
| | |
01/07/24 |
Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) dropped from Russell 2000 Dynamic Index
| | |
01/07/24 |
Cerevel Therapeutics Holdings, Inc.(NasdaqCM:CERE) added to Russell 1000 Growth Index
| | |
14/05/24 |
Cerevel Therapeutics Holdings Insider Sold Shares Worth $2,105,125, According to a Recent SEC Filing
| | |
08/05/24 |
Cerevel Therapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
| | |
19/04/24 |
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease
| | |
18/04/24 |
Cerevel Therapeutics' Potential Parkinson's Treatment Meets Primary Endpoint in Phase 3 Study
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
